Clinical Trials

Accrual Status
Limit to SWOG Trials

654 Results

Active Filters

Closed
Phase
Accrual
73%
Published
SWOG Clinical Trial Number
S0941

Phase II Study of Sorafenib (NSC-724772) and Erlotinib (NSC-718781) in Patients with Advanced Gallbladder Carcinoma or Cholangiocarcinoma

Research Committee(s)
Gastrointestinal Cancer
Activated
04-15-2010
Closed
09-15-2011
ClinicalTrials.gov Registry Number
NCT01093222
Closed
Phase
Accrual
91%
Published
SWOG Clinical Trial Number
S0905

A Phase I / Randomized Phase II Study of Cediranib (NSC #732208) Versus Placebo in Combination with Cisplatin and Pemetrexed in Chemonaive Patients with Malignant Pleural Mesothelioma

Status Notes
This study permanently closed to accrual February 15, 2016.
Research Committee(s)
Lung Cancer
Activated
03-15-2010
Closed
02-15-2016
ClinicalTrials.gov Registry Number
NCT01064648
Closed
Phase
Accrual
99%
Published
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0715

Randomized Placebo-Controlled Trial of Acetyl L-Carnitine for the Prevention of Taxane Induced Neuropathy

Research Committee(s)
Symptom Management and Survivorship
Breast Cancer
Cancer Survivorship
Molecular Epidemiology
Activated
09-15-2009
Closed
02-01-2011
Closed
Phase
Accrual
100%
Published
Closed
Phase
Accrual
78%
Published
SWOG Clinical Trial Number
S0819

A Randomized, Phase III Study Comparing Carboplatin/Paclitaxel or Carboplatin/Paclitaxel/Bevacizumab with or without Concurrent Cetuximab in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)

Status Notes
Status Notes: NOTE: The url for ordering specimen kits for this study has changed. Please use the following link: https://ricapps.nationwidechildrens.org/KitManagement
Research Committee(s)
Lung Cancer
Activated
07-15-2009
Closed
05-01-2015
ClinicalTrials.gov Registry Number
NCT00946712
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0816
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0701

A Phase III Randomized Trial of Three Antibiotic Regimens to Eradicate Helicobacter Pylori

Research Committee(s)
Prevention, Screening, and Surveillance
Activated
06-16-2009
Closed
06-30-2010
ClinicalTrials.gov Registry Number
NCT01061437
Closed
Phase
Accrual
100%
Published
Closed
Phase
Accrual
94%
Published
SWOG Clinical Trial Number
S0713

A Phase II Study of Oxaliplatin, Capecitabine, Cetuximab and Radiation in Pre-operative Therapy of Rectal Cancer

Research Committee(s)
Gastrointestinal Cancer
Activated
02-01-2009
Closed
04-15-2013
ClinicalTrials.gov Registry Number
NCT00686166
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0702

"A Prospective Observational Multicenter Cohort Study to Assess the Incidence of Osteonecrosis of the Jaw (ONJ) in Cancer Patients with Bone Metastases Starting Zoledronic Acid Treatment"

Status Notes
Status Notes: NOTE: The url for ordering specimen kits for this study has changed. Please use the following link: https://ricapps.nationwidechildrens.org/KitManagement
Research Committee(s)
Symptom Management and Survivorship
Breast Cancer
Genitourinary Cancer
Lung Cancer
Myeloma
Activated
12-15-2008
Closed
12-13-2013
ClinicalTrials.gov Registry Number
NCT00874211
Closed
Phase
Accrual
93%
Published
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0809

A Phase II Trial of Adjuvant Capecitabine/Gemcitabine Chemotherapy Followed by Concurrent Capecitabine and Radiotherapy in Extrahepatic Cholangiocarcinoma (EHCC)

Research Committee(s)
Gastrointestinal Cancer
Activated
12-01-2008
Closed
10-01-2012
ClinicalTrials.gov Registry Number
NCT00789958
Closed
Phase
Accrual
54%
Published
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0722

A Phase II Trial of mTOR Inhibitor, Everolimus, (RAD001) in Malignant Pleural Mesothelioma (MPM)

Research Committee(s)
Lung Cancer
Activated
12-01-2008
Closed
09-15-2011
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0720
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0000D
Closed
Phase
Accrual
2%
Published
SWOG Clinical Trial Number
S0502

A Phase III Randomized Study of Imatinib, with or without Bevacizumab (NSC-704865), in Patients with Metastatic or Unresectable Gastrointestinal Stromal Tumors

Research Committee(s)
Gastrointestinal Cancer
Activated
04-15-2008
Closed
10-01-2009
ClinicalTrials.gov Registry Number
NCT00324987
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0777

A Randomized Phase III Trial of CC-5013 (lenalidomide, NSD-703813) and Low Dose Dexamethasone (LLD) versus Bortezomib (PS-341, NSC-681239), Lenalidomide and Low Dose Dexamethasone (BLLD) for Induction, in Patients with Previously Untreated Multiple Myeloma without an Intent for Immediate Autologous Stem Cell Transplant

Status Notes
Revision #24 requires sites to contact all patients that have been enrolled, including those that have completed treatment and follow-up, to offer them participation in extended follow-up.
Research Committee(s)
Myeloma
Activated
04-01-2008
Closed
02-01-2012